Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors

다국어 초록 (Multilingual Abstract)

Metastatic mature teratoma is a common radiologic and histopathologic finding after chemotherapy for metastatic nonseminomatous germ cell tumors. The leading theory for these residual tumors is the selective chemotherapy resistance of teratomas versus the high chemotherapy sensitivity of the embryonal components. Growing teratoma syndrome is a relatively rare phenomenon defined as an enlarging residual mass histologically proven to be a mature teratoma in the setting of normal serum tumor markers. Metastatic mature teratomas should be resected because of their malignant potential and occasional progression to growing teratoma syndrome with the invasion of the surrounding structures. CT is the preferred imaging modality for post-chemotherapy surveillance and should cover all sites of potential metastatic disease. This article reviews the clinical, pathologic, and multimodality imaging features of metastatic mature teratomas in patients with primary testicular non-seminomatous germ cell tumors.

참고문헌 (Reference)

1 Pfannenberg AC, "The role of [18F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management" 22 : 132-139, 2004

2 André F, "The growing teratoma syndrome: results of therapy and longterm follow-up of 33 patients" 36 : 1389-1394, 2000

3 Coscojuela P, "The growing teratoma syndrome: radiologic findings in four cases" 12 : 138-140, 1991

4 Lorigan JG, "The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis" 151 : 325-329, 1988

5 Kattan J, "The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary" 49 : 395-399, 1993

6 Chen LT, "The growing teratoma syndrome. A case of primary mediastinal nonseminomatous germ cell tumor treated with chemotherapy and radiotherapy" 98 : 231-233, 1990

7 Inaoka T, "The growing teratoma syndrome secondary to immature teratoma of the ovary" 13 : 2115-2118, 2003

8 Jeffery GM, "The growing teratoma syndrome" 67 : 195-202, 1991

9 Logothetis CJ, "The growing teratoma syndrome" 50 : 1629-1635, 1982

10 Gilligan T, "Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology" 17 : 1529-1554, 2019

11 Spiess PE, "Surgical management of growing teratoma syndrome:the M. D. Anderson cancer center experience" 177 : 1330-1334, 2007

12 Steyerberg EW, "Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups" 13 : 1177-1187, 1995

13 Miranda Ede P, "Predicting necrosis in residual mass analysis after retroperitoneal lymph node dissection: a retrospective study" 10 : 203-, 2012

14 Oldenburg J, "Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses" 21 : 3310-3317, 2003

15 Panicek DM, "Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy" 175 : 499-502, 1990

16 Sonneveld DJ, "Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach" 82 : 1343-1351, 1998

17 Carver BS, "Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma" 25 : 1033-1037, 2007

18 Han NY, "Imaging features of growing teratoma syndrome following a malignant ovarian germ cell tumor" 38 : 551-557, 2014

19 Maroto P, "Growing teratoma syndrome:experience of a single institution" 32 : 305-309, 1997

20 Lee DJ, "Growing teratoma syndrome: clinical and radiographic characteristics" 21 : 905-908, 2014

21 van der Gaast A, "Growing teratoma syndrome successfully treated with lymphoblastoid interferon" 19 : 257-258, 1991

22 Kikawa S, "Growing teratoma syndrome of the ovary: a case report with FDG-PET findings" 37 : 926-932, 2011

23 Umekawa T, "Growing teratoma syndrome as an unusual cause of gliomatosis peritonei: a case report" 99 : 761-763, 2005

24 Aide N, "Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence?" 25 : 4494-4496, 2007

25 Paffenholz P, "Diagnosis and management of the growing teratoma syndrome: a singlecenter experience and review of the literature" 36 : 529.e23-529.e30, 2018

26 Daneshmand S, "Contemporary management of postchemotherapy testis cancer" 62 : 867-876, 2012

27 Shayegan B, "Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour" 99 : 993-997, 2007

28 DiSaia PJ, "Chemotherapeutic retroconversion of immature teratoma of the ovary" 49 : 346-350, 1977

29 Stomper PC, "CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?" 180 : 711-714, 1991

30 Bahrami A, "An overview of testicular germ cell tumors" 131 : 1267-1280, 2007